IMPAACT 2002: Cognitive Behavioral Therapy and Medication Management for Treatment of Depression in US Youth With HIV
Public ClinicalTrials.gov record NCT02939131. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
IMPAACT 2002: Combined Cognitive Behavioral Therapy and a Medication Management Algorithm for Treatment of Depression Among Youth Living With HIV in the United States
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
IMPAACT 2002 is a prospective, multi-site, two-arm, cluster-randomized study to evaluate whether a health and wellness Cognitive Behavioral Therapy and Medication Management (COMB-R) intervention for depression demonstrates improved depression and medical outcomes for HIV-infected youth in the United States (US) compared to enhanced standard care (ESC).
Study identification
- NCT ID
- NCT02939131
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 156 participants
Conditions and interventions
Conditions
Interventions
- Health and Wellness Combined Cognitive Behavioral Therapy and a Medication Management Algorithm Behavioral
- Enhanced Standard of Care Behavioral
Behavioral
Eligibility (public fields only)
- Age range
- 12 Years to 24 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 5, 2017
- Primary completion
- Sep 11, 2019
- Completion
- Jan 20, 2020
- Last update posted
- Mar 2, 2021
2017 – 2020
United States locations
- U.S. sites
- 13
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Southern California - MCA Center (CRS 5048), | Alhambra | California | 91803 | — |
| University California, San Diego (CRS 4601) | La Jolla | California | 92093 | — |
| David Geffen School of Medicine at UCLA (CRS 5112) | Los Angeles | California | 90095 | — |
| Children's Hospital of Colorado (CRS 5052) | Aurora | Colorado | 80045 | — |
| Children's Diagnostic and Treatment Center (CRS 5055) | Fort Lauderdale | Florida | 33316 | — |
| Emory University School of Medicine (CRS 5030) | Atlanta | Georgia | 30308 | — |
| Rush University Medical Center (CRS 5083) | Chicago | Illinois | 60612 | — |
| Johns Hopkins University School of Medicine (CRS 5092) | Baltimore | Maryland | 21287 | — |
| Stony Brook University Medical Center (CRS 5040) | Stony Brook | New York | 11794 | — |
| Bronx-Lebanon Hospital Center (CRS 5114) | The Bronx | New York | 10457 | — |
| Jacobi Medical Center (CRS 5013) | The Bronx | New York | 10461 | — |
| St Jude Children's Research Hospital (CRS 6501) | Memphis | Tennessee | 38105 | — |
| Texas Children's/Baylor (CRS 3801) | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02939131, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 2, 2021 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02939131 live on ClinicalTrials.gov.